Recent LQDA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 10:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 10:27:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 10:25:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/08/2024 04:15:08 AM
- Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH) • GlobeNewswire Inc. • 06/18/2024 12:42:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 01:25:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 01:24:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:30:28 AM
- District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch • GlobeNewswire Inc. • 06/03/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 09:00:48 PM
- Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:30:43 PM
- Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 09:43:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 09:10:36 PM
- Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD • GlobeNewswire Inc. • 05/10/2024 12:00:00 PM
- Liquidia Corporation to Present at BofA Securities Health Care Conference 2024 • GlobeNewswire Inc. • 05/07/2024 12:30:00 PM
- Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024 • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
- Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 01:00:10 PM
- Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder • GlobeNewswire Inc. • 04/01/2024 10:00:44 AM
- Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/13/2024 10:00:00 AM
- Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024 • GlobeNewswire Inc. • 03/06/2024 11:30:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:07:54 AM
- Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress • GlobeNewswire Inc. • 01/30/2024 11:30:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 12:01:42 PM
- Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder • GlobeNewswire Inc. • 01/25/2024 11:00:57 AM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM